Mitotech-19

N/A

Report date: 2025/01/26 17:18:26
NME

Base Information

Drug NameMitotech-19
Drug Alias NameSARS-CoV-2 Therapy (Mitotech)SkQ1-Based Antioxidant (Mitotech)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionantioxidant
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryLuxembourg
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMitotech Sa
China Registration ClassN/A

Develop Information

Active CompaniesMitotech Sa
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A